Congenital mesoblastic nephroma (CMN), also known as fetal, mesenchymal, or leiomyomatous hamartoma, is a rare, benign congenital renal tumor in children, but it is the most common renal tumor under the age of 6 months, accounting for almost half of renal tumors in these age groups. 1 Knowledge of this tumor and its presentation is important. CMN can be diagnosed by sonography during antenatal examination. 2 Although this tumor is benign, it can cause severe obstetric and neonatal complications such as polyhydramnios and prematurity. The biological behavior and prognosis after complete tumor removal are excellent. 3 Presented is a new case of cellular CMN diagnosed by antenatal sonography.
Case Report
A woman in her late 20s, gravida 5, para 2, abortion 2, was referred to our hospital at 28 weeks' Congenital mesoblastic nephroma is a rare renal tumor of early infancy with a favorable outcome after complete surgical removal. It consists of a heterogeneous group of spindle cell tumors. Early and accurate prenatal diagnosis of the renal tumor may improve the outcome of affected pregnancies by implementing the best strategy for prenatal management and delivery. But detection of congenital mesoblastic nephroma in a fetus is rare. To the authors' knowledge, there are fewer than 30 reports of a prenatal diagnosis of a mesoblastic nephroma in the literature. This case describes the prenatal sonographic diagnosis of cellular congenital mesoblastic nephroma.
Congenital
Key words: prenatal diagnosis, congenital mesoblastic nephroma, ultrasonography gestation for fetal abdominal mass and polyhydramnios. Targeted sonography showed a unilateral and heterogeneous echogenic solid mass measuring about 5.4 × 4.8 × 4.0 cm on the left side of the fetal abdomen ( Figure 1 ). A thin hypoechoic rim surrounded the tumor, and the Doppler study revealed a spectrum of both venous and arterial waveforms in the tumor rim. The amniotic fluid index measured 26.0 cm. A normal left kidney was not visualized, which suggested renal origin of the described mass. The right kidney was normal. The patient and fetus were followed by sonography at 2-week intervals. The mass continued to grow.
At 38 weeks' gestation, a repeat cesarean section was performed. A male neonate was delivered, weighing 3600 g and with Apgar scores of 8 at 1 minute and 9 at 5 minutes. At birth, physical examination was normal. Abdominal sonography performed after birth revealed a solid mass measuring 6.0 × 5.0 × 4.0 cm in diameter. Three days after birth, a left nephrectomy was performed. In general, the tumor was a firm, spherical lobulated mass expanding the upper pole of the kidney, measuring 6 × 5.5 × 4.5 cm. The microscopic appearance was that of an unencapsulated mesenchymal cellular spindle cell neoplasm, which was infiltrating the adjacent renal parenchyma with tubules and glomeruli encased in the neoplastic growth ( Figure 2 ). Mitoses were numerous, with a counting of 25 per 10 high power field (HPF; normal range, 0-2 mitosis). Immunohistochemically, these spindle cells were reactive with vimentin (Clone V9, Neomarkers) and smooth muscle actin (Clone 1A4, Labvision). The tumor was negative with cytokeratin (Clone AE1/AE3, Neomarkers), desmin (Clone D33, DBS), and S-100 (Clone 4C4.9, Neomarkers). Clinical, microscopic, and immunohistochemical findings revealed a mesoblastic nephroma for the tumor.
Discussion
Congenital mesoblastic nephroma is a rare, benign renal tumor, representing only 3% to 5% of renal tumors in children. 4, 5 It is often present at birth as an abdominal mass. The mean age of presentation is three months. It is usually unilateral and occurs with a similar incidence in both sexes. When a fetal intra-abdominal solid tumor is found, the differential diagnosis of fetal abdominal solid tumor includes CMN, Wilms tumor of the kidney, and congenital adrenal neuroblastoma. Previously confused with congenital Wilms tumor, CMN is now recognized as a distinct entity characterized by a more benign clinical behavior and lack of the malignant epithelial components typical of Wilms tumor. Wilms tumor characteristically invades the normal renal parenchyma. Areas of hemorrhage and necrosis may be seen within the mass. With sonography, classic CMN may appear as a hypoechogenic tumor with an echogenic rim or as a monogeneous or heterogeneous solid mass with no discernible rim. Differentiation from Wilms tumor is not possible sonographically, and the distinction can only be made pathologically. 5 Wilms tumor is characterized by a blastemal, epithelial, and mesenchymal component. It usually contains three components, but biphasic and monophasic tumors can be observed. As for congenital adrenal neuroblastoma, it appears separated from the kidney with distinct margins and has a mixed echotexture with solid and cystic components. Magnetic resonance imaging (MRI) can play an important role in the diagnosis of fetal intra-abdominal tumor because of its ability to distinguish the outline of the tumor from the normal kidney and adrenal gland clearly. 5 Congenital mesoblastic nephroma is rarely detected in the antenatal period. A search of the literature suggests that there have been fewer than 30 reported cases of antenatal diagnosis of mesoblastic nephroma. 5 Ehman et al. 6 reported the first case of the mesoblastic nephroma, detected prenatally by sonography in a twin fetus at 35 weeks' gestation.
Although CMN is a benign tumor, it can cause severe obstetric and neonatal complications such as polyhydramnios and prematurity. Polyhydramnios associated with CMN has been described in most of the published case reports. Leclair et al. 7 reported that 71% of renal tumors diagnosed antenatally had complications. Presentation of CMN in the perinatal period has been associated with multiple complications, including polyhydramnios, hydrops, fetal distress, prematurity, hemodynamic instability, hypertension, intraoperative bleeding, tumor rupture, and death. Once the perinatal period has passed, the outcome is good, with no recurrence and an overall survival rate of 96%. 7, 8 Polyhydramnios was found in the presented case, and no other additional findings were noted. Prenatal diagnosis of mesoblastic nephroma by sonography generally occurs during the third trimester. The earliest gestational age at which a mesoblastic nephroma has been diagnosed is 22 weeks. 5 The presented patient's gestational age was 28 weeks when diagnosed.
In general, CMN can present as a large (4-8 cm), unilateral renal mass with nodular densities or diffuse-renal enlargement, and most are centered near the hilus of the kidney. The tumor is usually well circumscribed, but it may be seen infiltrating the renal parenchyma and even the perinatal fat. Congenital mesoblastic nephroma has three morphological subtypes that are distinguishable histologically: classical, cellular, and mixed type. Cellular types can potentially be malignant and capable of recurrence and metastasis. 9 This subtype can recur or even metastasize almost exclusively in patients older than three months of age. 10, 11 On the other hand, both classic and cellular tumors have an excellent prognosis in patients younger than age 3 months. 12 In this case, the tumor was found to have an increased nuclei-cytoplasmic ratio, higher mitotic rate, and focal necrosis. In addition, the tumor infiltrated the renal capsule, and metastasis was absent.
Congenital mesoblastic nephroma almost always follows a benign clinical course if diagnosed at less than 3 months of age and if completely excised surgically. CMN of the cellular variant requires a strict, careful follow-up, and additional chemotherapy can be considered for those cases in which surgical margins are involved histologically. 10 Prenatal detection provides the opportunity for optimal pregnancy management. Management of complications through amniotic fluid reduction and tocolysis may delay prematurity. Detection of the developing cardiac decompensation and fetal hydrops can aid with the planning of labor and postnatal management.
In conclusion, the prenatal diagnosis of congenital mesoblastic nephroma has become possible, particularly by sonography. Sonographic identification is based mainly on the presence of polyhydramnios and a unilateral, well-defined solid mass at the level of the renal fossa. Accurate prenatal diagnosis may improve the outcome of affected pregnancies by enabling the strategy of management and delivery to be planned.
